Back
Align Technology 10K Form
Buy
54
ALGN
Align Technology
Last Price:
228.22
Seasonality Move:
17.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | ALGN/Align Technology Quarterly |
2024-02-28 | 10K | ALGN/Align Technology Annual |
2023-11-03 | 10Q | ALGN/Align Technology Quarterly |
2023-08-04 | 10Q | ALGN/Align Technology Quarterly |
2023-05-05 | 10Q | ALGN/Align Technology Quarterly |
2023-02-27 | 10K | ALGN/Align Technology Annual |
Receive ALGN News And Ratings
See the #1 stock for the next 7 days that we like better than ALGN
ALGN Financial Statistics
Sales & Book Value
Annual Sales: | $3.86B |
---|---|
Cash Flow: | $233.86M |
Price / Cash Flow: | 46.38 |
Annual Sales: | $52.76 |
Price / Book: | 4.35 |
Profitability
EPS (TTM): | 5.86000 |
---|---|
Net Income (TTM): | $441.57M |
Gross Margin: | $2.71B |
Return on Equity: | 11.69% |
Return on Assets: | 7.1% |
Align Technology Earnings Forecast
Key Align Technology Financial Ratios
- The Gross Profit Margin over the past 25 years for ALGN is 70.08%.
- The Selling, General & Administrative Expenses for ALGN have been equal to 44.10% of Gross Profit Margin.
- The Research & Development expenses have been 8.98% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of ALGN is 11.52% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
Align Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ALGN |
CUSIP: | 016255 |
Website: | aligntech.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.26 |
Quick Ratio: | 1.07 |
Price-to-Earnings
Trailing P/E Ratio: | 39.57 |
---|---|
Forward P/E Ratio: | 22.4 |
ALGN Technical Analysis vs Fundamental Analysis
Buy
54
Align Technology (ALGN)
is a Buy
Is Align Technology a Buy or a Sell?
-
Align Technology stock is rated a Buy
The current Align Technology [ALGN] share price is $223.87. The Score for ALGN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.